BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-18 out of 18 found
  Current Search:  elestrin: 18     

HTML
100%
Antares Pharma to Present at the 22nd Annual ROTH OC Growth Stock Conference
EWING, N.J.-- (BUSINESS WIRE) -- (NYSE Amex: AIS) today announced that Paul K.

Wotton, Ph.D., President and Chief Executive Officer, will present at the 22nd Annual Roth OC Growth Stock Conference on Wednesday, March 17, 2010 at 12:30 p.m.

ET (Eastern Time)...

SmartBrief:  Mar 12 2010 5:55AM
Matching: elestrin
Find similar documents
HTML
100%
Antares Pharma to Present at the 22nd Annual ROTH OC Growth Stock Conference
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc.

(NYSE Amex: AIS) today announced that Paul K.

Wotton, Ph.D., President and Chief Executive Officer, will present at the 22nd Annual Roth OC Growth Stock Conference on Wednesday, March 17, 2010 at 12:30 p.m....

Yahoo! Canada:  Mar 12 2010 5:29AM
Matching: elestrin
Find similar documents
HTML
100%
Antares Pharma to Present at the 22nd Annual ROTH OC Growth Stock Conference
A live audio webcast of the presentation will be available at http://www.wsw.com/webcast/roth23/ais/.

About Antares Pharma Antares Pharma is an emerging pharma that focuses on self-injection pharmaceutical products and technologies and topical gel-based...

Therapeutics Daily:  Mar 12 2010 4:50AM
Matching: elestrin
Find similar documents
HTML
100%
Antares Pharma to Present at the 22nd Annual ROTH OC Growth Stock Conference
- Antares Pharma, Inc.

(NYSE Amex: AIS) today announced that Paul K.

Wotton, Ph.

D., President and Chief Executive Officer, will present at the 22nd Annual Roth OC Growth Stock Conference on Wednesday, March 17, 2010 at 12:30 p.m.

ET (Eastern Time).

A...

Pharma Live:  Mar 11 2010 10:15PM
Matching: elestrin
Find similar documents
HTML
100%
Antares Pharma to Present at the 22nd Annual ROTH OC Growth Stock Conference
Antares Pharma, Inc.

(NYSE Amex: AIS) today announced that Paul K.

Wotton, Ph.

D., President and Chief Executive Officer, will present at the 22 nd Annual Roth OC Growth Stock Conference on Wednesday, March 17, 2010 at 12:30 p.m.

ET (Eastern Time).

A...

PR inside:  Mar 11 2010 1:44PM
Matching: elestrin
Find similar documents
HTML
100%
Antares Pharma to Present at the 22nd Annual ROTH OC Growth Stock Conference
Antares Pharma, Inc.

(NYSE Amex: AIS) today announced that Paul K.

Wotton, Ph.D., President and Chief Executive Officer, will present at the 22nd Annual Roth OC Growth Stock Conference on Wednesday, March 17, 2010 at 12:30 p.m.

ET (Eastern Time).

A live...

FinanzNachrichten.de:  Mar 11 2010 1:36PM
Matching: elestrin
Find similar documents
HTML
100%
Antares Pharma to Present at the Cowen and Company 30th Annual Health Care Conference
EWING, N.J.-- (BUSINESS WIRE) -- (NYSE Amex: AIS) today announced that Paul K.

Wotton, Ph.D., President and Chief Executive Officer will present at the Cowen and Company 30th Annual Health Care Conference on Wednesday, March 10, 2010 at 8:45 a.m.

ET ...

SmartBrief:  Mar 6 2010 4:22PM
Matching: elestrin
Find similar documents
HTML
100%
BioSante Pharmaceuticals Eyes $18 Million Raise - Zibb.com
Company: BioSante Pharmaceuticals, Inc.

(BPAX) (Comment on this article at http://www.financialwire.net/2010/03/05/biosante-pharmaceuticals-eyes-18-million-raise/) The company said it expects to receive net proceeds of around $17.5 million.

Under the deal,...

Zibb:  Mar 5 2010 2:10PM
Matching: elestrin
Find similar documents
HTML
100%
BioSante Pharmaceuticals Eyes $18 Million Raise
(Comment on this article at http://www.financialwire.net/2010/03/05/biosante-pharmaceuticals-eyes-18-million-raise/) The company said it expects to receive net proceeds of around $17.5 million.

Under the deal, BioSante has agreed to sell an aggregate of...

TradingMarkets:  Mar 5 2010 1:33PM
Matching: elestrin
Find similar documents
HTML
100%
Antares Pharma to Present at the Cowen and Company 30th Annual Health Care Conference
EWING, N.J.(BUSINESS WIRE) Antares Pharma, Inc.

(NYSE Amex: AIS) today announced that Paul K.

Wotton, Ph.

D., President and Chief Executive Officer will present at the Cowen and Company 30th Annual Health Care Conference on Wednesday, March 10, 2010 at 8...

Pharmacy Choice:  Mar 5 2010 1:35AM
Matching: elestrin
Find similar documents
HTML
100%
Antares Pharma to Present at the Cowen and Company 30th Annual Health Care Conference
- Antares Pharma, Inc.

(NYSE Amex: AIS) today announced that Paul K.

Wotton, Ph.

D., President and Chief Executive Officer will present at the Cowen and Company 30th Annual Health Care Conference on Wednesday, March 10, 2010 at 8:45 a.m.

ET (Eastern...

Pharma Live:  Mar 4 2010 8:10PM
Matching: elestrin
Find similar documents
HTML
100%
Antares Pharma to Present at the Cowen and Company 30th Annual Health Care Conference
An audio web cast of the presentation will be available under the investor relations section of the Antares website at www.antarespharma.com.

About Antares Pharma Antares Pharma is an emerging pharma that focuses on self-injection pharmaceutical products and...

Therapeutics Daily:  Mar 4 2010 7:23PM
Matching: elestrin
Find similar documents
HTML
100%
Antares Pharma to Present at the Cowen and Company 30th Annual Health Care Conference
An audio web cast of the presentation will be available under the investor relations section of the Antares website at www.antarespharma.com.

About Antares Pharma Antares Pharma is an emerging pharma that focuses on self-injection pharmaceutical products and...

TradingMarkets:  Mar 4 2010 2:46PM
Matching: elestrin
Find similar documents
HTML
100%
Antares Pharma to Present at the Cowen and Company 30th Annual Health Care Conference
Antares Pharma, Inc.

(NYSE Amex: AIS) today announced that Paul K.

Wotton, Ph.D., President and Chief Executive Officer will present at the Cowen and Company 30 th Annual Health Care Conference on Wednesday, March 10, 2010 at 8:45 a.m.

ET (Eastern Time)....

PR inside:  Mar 4 2010 1:55PM
Matching: elestrin
Find similar documents
HTML
100%
Antares Pharma And Population Council Announce Positive Phase 2 Trial Results
First Transdermal Contraceptive ATD Gel Contains Nestorone EWING, NJ, AND NEW YORK, NY (January 11, 2010) - Antares Pharma, Inc.

(NYSE Amex: AIS) and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel...

Pharma Live:  Jan 11 2010 10:34PM
Matching: elestrin
Find similar documents
HTML
100%
Antares Pharma and Population Council Announce Positive Phase 2 Trial Results
EWING, N.J.

& NEW YORK--(BUSINESS WIRE)--Antares Pharma, Inc.

(NYSE This first of its kind contraceptive gel may offer an attractive option for women.

The combination of Nestorone, a highly potent and versatile synthetic progestin, and the natural...

Business Wire via Yahoo!:  Jan 11 2010 1:52PM
Matching: elestrin
Find similar documents
HTML
100%
BioSante Pharmaceuticals, Inc. To Present At OneMedForum and Biotech Showcase Conferences
- BioSante Pharmaceuticals, Inc.

(NASDAQ: BPAX) will present at the OneMedForum and Biotech Showcase Conferences in San Francisco.

Stephen M.

Simes, BioSante's president & CEO, will present at the OneMedForum on Tuesday January 12, 2010 at 11:30...

Pharma Live:  Jan 6 2010 6:04PM
Matching: elestrin
Find similar documents
HTML
100%
BioSante Pharmaceuticals, Inc. To Present At OneMedForum and Biotech Showcase Conferences
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc.

(NASDAQ: BPAX - News) will present at the OneMedForum and Biotech Showcase Conferences in San Francisco.

Stephen M.

Simes, BioSantes president & CEO, will present at the...

Business Wire via Yahoo!:  Jan 6 2010 1:14PM
Matching: elestrin
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.